ALFA FinderNSE filing, NSE: BANKBARODA. Summary written from the filing by ALFA Finder's alert engine.
Bank of Baroda: key numbers
- Share price
- ₹273.84
- Market cap
- ₹1,41,613 Cr
- Revenue (annual)
- ₹1,34,298 Cr
- Net profit (annual)
- ₹19,846 Cr
- P/E (TTM)
- 7.2×Sector 21.0×
- Promoter holding
- 63.97%+0.00% QoQ
- FII holding
- 10.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bank of Baroda
All →Bank of Baroda Other Announcement
Bank of Baroda intimated that its RTA, KFin Technologies, is shifting its corporate office to a new Kokapet, Hyderabad address effective 1 December 2026. The registered office remains unchanged.
Bank of Baroda Earnings Call Transcript: Key Takeaways
Q2 FY27 PAT ₹6,532 Cr (+38.8% YoY) includes ₹349 Cr NSE-stake gain and is cushioned by ₹1,300 Cr NPA and ₹300 Cr contingency provisions. Growth is flattered by FCNRB inflows.
Bank of Baroda Annual General Meeting
Bank of Baroda will hold an EGM on 21 December 2026 to elect one shareholder director. The cut-off date for shareholders is 20 November 2026.
Bank of Baroda Investor Presentation: Key Takeaways
Q2FY27 PAT ₹6,532 cr (+35.8% YoY) and operating profit ₹11,430 cr (+50.9%), lifted by ₹4,093 cr treasury income. Global advances +18.3%, deposits +16.4%.
Bank of Baroda Q2 FY27 Results: Net Profit ₹6,737 Cr, Up 31.2% YoY
Bank of Baroda reported revenue from operations of ₹37,021 Cr (+11.1% YoY) and net profit of ₹6,737 Cr (+31.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,737 Cr · +31.2% YoY
Bank of Baroda Legal & Regulatory
Bank of Baroda clarified media-reported interim applications filed by Dr. BR Shetty in the Bombay High Court. The bank says it has not been served and calls the allegations untested.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr